By Josh White
Date: Friday 22 May 2026
(Sharecast News) - RUA Life Sciences said in an update on Friday that it expected to report a smaller EBITDA loss, broadly reaching breakeven on an adjusted basis, after revenue growth in its UK contract development and manufacturing and biomaterials businesses offset weaker trading at Abiss.
No recent information was found.
| Stalemate in legal dispute at AorTech | 30-Sep-2014 | The Herald |
| AIM hopes help Aortech to soar | 25-Nov-2011 | The Herald |
| AorTech surges on supply agreement | 19-May-2009 | The Herald |
| Director Dealings: Archial proves attractive | 13-Apr-2009 | Scotland on Sunday |
| AorTech founders sell shares to board | 07-Apr-2009 | The Herald |
| AorTech leads gainers on latest Scottish StockWa... | 04-Nov-2006 | The Scotsman |
| Smaller stock to watch | 26-Oct-2006 | Times |
| Reeling Plusnet at two-year low as broadband bat... | 08-Aug-2006 | Times |
| Vodafone is ringing a few alarm bells | 21-Jan-2006 | The Scotsman |
| Tomb Raider company takes a hit | 21-Jan-2006 | Guardian |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 19.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 25.60 |
| 52 Week Low | 10.50 |
| Volume | 0 |
| Shares Issued | 62.06m |
| Market Cap | £11.79m |
| RiskGrade | 290 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| CEO | William D Brown |
| CFO | Lachlan Smith |
You are here: research